Company / Shares Outstanding
LENZ Therapeutics, Inc. Shares Outstanding History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
27.5M
FY2025
5-year range
2.0M / 54.9M
FY2021-FY2025
Trend
+29.3%
vs FY2024
Sector context
#196 of 212
Health Care
What the data says
Among 212 Health Care companies, LENZ Therapeutics, Inc. is in the top 8% for shares outstanding. Increased from 1959091.00 to 27518439.00 over the past 2 years.
Based on SEC 10-K filings.
27518439.00 in FY2025 with a 5-year CAGR of +64.5%.
Increased from 1959091.00 to 27518439.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -20.6%
- 5-Year CAGR
- +64.5%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 212This company 27.5M Sector average 306.7M
▼
-91.0% below sector average
Key checks
Key Insights
- In FY2025, shares outstanding increased 29.3% year-over-year.
- Ranks #196 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2022.
- Lowest shares outstanding in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 27.5M | +29.3% |
| FY2024 | 21.3M | +986.3% |
| FY2023 | 2.0M | -96.4% |
| FY2022 | 54.9M | +89.7% |
| FY2021 | 28.9M | +1166.1% |
| FY2020 | 2.3M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026